Skip to contentJ
JRSIS HEALTH CARE Corp
J
JRSSJRSIS HEALTH CARE Corp Q3 2020 · 10-Q
Revenue$10.02M$10.02M+29.0% vs Q3 2019 Net Income$1.03M$1.03M+117.2% vs Q3 2019 EPS Diluted$0.04$0.04+61.2% vs Q3 2019 Operating Income$1,875,765+75.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
JRSIS HEALTH CARE Corp · CIK 1597892 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$825,778−48.0% Margins · derivedOperating margin18.7%+4.9 pt vs Q3 2019
Net margin10.3%+4.2 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 13, 2020 · 44 d after period end